It does not necessarily reflect the view of The Herald. The coastal village of Ferring once played host to Edward, Prince of Wales – who eventually became King and abdicated to marry American ...

First results from a Phase 3 trial conducted across 25 centers in Japan highlight Ferring’s ongoing commitment to establish ADSTILADRIN as the new standard of care and backbone therapy for non ...

Ferring Pharmaceuticals announced strong performance results for 2024, with one part of the announcement standing out as being particularly good for the company. Last year, Ferring had record sales of ...

Ferring Pharmaceuticals presented the initial results from an ongoing Phase 3 trial (NCT05704244) in Japan assessing the efficacy and safety of ADSTILADRIN® (nadofaragene firadenovec-vncg) in ...

For a breakdown of the individual adjustments see table "Non-IFRS Operating Expense Adjustments by Functional Areas" in this Quarterly Statement. Cloud ERP Suite references the portfolio of ...

With an FDA review underway, Johnson & Johnson is aiming to “fundamentally change” how bladder cancer is treated. That’s how Biljana Naumovic, president of J&J’s U.S. solid tumor business ...

C. diff causes nearly 30,000 deaths each year in the US, says Ferring, and recurrent infections with the bacterium make up 10%-15% of all hospital-treated infections.

The US Food and Drug Administration (FDA) has approved Swiss drugmaker Ferring Pharmaceuticals’ Adstiladrin (nadofaragene firedenovec-vncg) for the treatment of adult patients with high-risk ...